title: Neprilysin impedes islet amyloid formation by inhibition of fibril formation rather than peptide degradation.
abstract: Deposition of islet amyloid polypeptide (IAPP) as islet amyloid in type 2 diabetes contributes to loss of beta-cell function and mass, yet the mechanism for its occurrence is unclear. Neprilysin is a metallopeptidase known to degrade amyloid in Alzheimer disease. We previously demonstrated neprilysin to be present in pancreatic islets and now sought to determine whether it plays a role in degrading islet amyloid. We used an in vitro model where cultured human IAPP (hIAPP) transgenic mouse islets develop amyloid and thereby have increased beta-cell apoptosis. Islet neprilysin activity was inhibited or up-regulated using a specific inhibitor or adenovirus encoding neprilysin, respectively. Following neprilysin inhibition, islet amyloid deposition and beta-cell apoptosis increased by 54 and 75%, respectively, whereas when neprilysin was up-regulated islet amyloid deposition and beta-cell apoptosis both decreased by 79%. To determine if neprilysin modulated amyloid deposition by cleaving hIAPP, analysis of hIAPP incubated with neprilysin was performed by mass spectrometry, which failed to demonstrate neprilysin-induced cleavage. Rather, neprilysin may act by reducing hIAPP fibrillogenesis, which we showed to be the case by fluorescence-based thioflavin T binding studies and electron microscopy. In summary, neprilysin decreases islet amyloid deposition by inhibiting hIAPP fibril formation, rather than degrading hIAPP. These findings suggest that targeting the role of neprilysin in IAPP fibril assembly, in addition to IAPP cleavage by other peptidases, may provide a novel approach to reduce and/or prevent islet amyloid deposition in type 2 diabetes.
authors.affiliation: Department of Medicine, Veterans Affairs Puget Sound Health Care System and University of Washington, Seattle, Washington 98108, USA.
authors.forename: Sakeneh
authors.initials: S
authors.lastname: Zraika
authors.forename: Kathryn
authors.initials: K
authors.lastname: Aston-Mourney
authors.forename: Peter
authors.initials: P
authors.lastname: Marek
authors.forename: Rebecca L
authors.initials: RL
authors.lastname: Hull
authors.forename: Pattie S
authors.initials: PS
authors.lastname: Green
authors.forename: Jayalakshmi
authors.initials: J
authors.lastname: Udayasankar
authors.forename: Shoba L
authors.initials: SL
authors.lastname: Subramanian
authors.forename: Daniel P
authors.initials: DP
authors.lastname: Raleigh
authors.forename: Steven E
authors.initials: SE
authors.lastname: Kahn
mesh_terms: D000682:Amyloid / Q000378:metabolism*; D000818:Animals; D017209:Apoptosis; D003921:Diabetes Mellitus, Experimental / Q000628:therapy; D005260:Female; D050417:Insulin-Secreting Cells / Q000378:metabolism*; D007515:Islets of Langerhans / Q000378:metabolism*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008811:Mice, Inbred DBA; D008822:Mice, Transgenic; D015260:Neprilysin / Q000737:chemistry / Q000502:physiology*; D010455:Peptides / Q000737:chemistry*; D011485:Protein Binding
chemical_list: D000682:Amyloid; D010455:Peptides; D015260:Neprilysin
references.citation: Diabetes. 1994 Dec;43(12):1457-61
references.pmid: 7958499
references.citation: FEBS Lett. 1989 Jul 17;251(1-2):261-4
references.pmid: 2666169
references.citation: Diabetologia. 1994 Feb;37(2):188-94
references.pmid: 8163054
references.citation: Methods Enzymol. 1995;248:263-83
references.pmid: 7674926
references.citation: Neurosci Res. 2002 May;43(1):39-56
references.pmid: 12074840
references.citation: Diabetes Res Clin Pract. 1992 Jan;15(1):97-102
references.pmid: 1541241
references.citation: Proc Natl Acad Sci U S A. 1996 Apr 16;93(8):3492-6
references.pmid: 8622964
references.citation: Peptides. 1995;16(4):647-52
references.pmid: 7479298
references.citation: Diabetologia. 2009 Apr;52(4):626-35
references.pmid: 19148619
references.citation: Cell Mol Life Sci. 2009 Apr;66(8):1321-5
references.pmid: 19266159
references.citation: Cell Mol Life Sci. 2008 Aug;65(16):2574-85
references.pmid: 18470479
references.citation: J Biol Chem. 2001 Jul 6;276(27):25612-20
references.pmid: 11342542
references.citation: Biochem J. 2002 May 1;363(Pt 3):697-705
references.pmid: 11964170
references.citation: Horm Metab Res. 1991 Dec;23(12):577-80
references.pmid: 1723393
references.citation: J Biol Chem. 2006 Aug 25;281(34):24566-74
references.pmid: 16787929
references.citation: J Neurosci. 2003 Mar 15;23(6):1992-6
references.pmid: 12657655
references.citation: Proc Natl Acad Sci U S A. 1990 Jul;87(13):5036-40
references.pmid: 2195544
references.citation: Science. 2001 May 25;292(5521):1550-2
references.pmid: 11375493
references.citation: Exp Cell Res. 1989 Aug;183(2):484-93
references.pmid: 2670595
references.citation: Cancer Cell. 2004 Jan;5(1):67-78
references.pmid: 14749127
references.citation: Biochemistry. 2008 Jun 3;47(22):6016-24
references.pmid: 18457428
references.citation: Curr Alzheimer Res. 2008 Apr;5(2):225-31
references.pmid: 18393807
references.citation: J Biol Chem. 2006 Oct 13;281(41):30471-8
references.pmid: 16912050
references.citation: Endocrinology. 1997 Apr;138(4):1736-41
references.pmid: 9075738
references.citation: Proc Natl Acad Sci U S A. 2007 Apr 3;104(14):5995-6000
references.pmid: 17389375
references.citation: Diabetes. 2007 Feb;56(2):304-10
references.pmid: 17259373
references.citation: J Biol Chem. 2000 Nov 24;275(47):36621-5
references.pmid: 10973971
references.citation: Diabetes. 2000 Dec;49(12):2056-62
references.pmid: 11118007
references.citation: Blood. 1996 Dec 1;88(11):4159-65
references.pmid: 8943850
references.citation: J Biol Chem. 2003 Sep 26;278(39):37314-20
references.pmid: 12867419
references.citation: Anticancer Res. 2002 Sep-Oct;22(5):2533-8
references.pmid: 12529960
references.citation: J Clin Endocrinol Metab. 2004 Aug;89(8):3629-43
references.pmid: 15292279
references.citation: Arch Biochem Biophys. 2002 Sep 15;405(2):275-9
references.pmid: 12220542
references.citation: Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2046-51
references.pmid: 16467158
references.citation: Am J Physiol Endocrinol Metab. 2004 Sep;287(3):E431-8
references.pmid: 15126240
references.citation: Diabetologia. 1990 May;33(5):285-9
references.pmid: 2198187
references.citation: Diabetes. 1990 May;39(5):634-8
references.pmid: 2185112
references.citation: Diabetologia. 2004 Feb;47(2):240-8
references.pmid: 14722647
references.citation: Diabetes. 2003 Sep;52(9):2315-20
references.pmid: 12941771
references.citation: J Biol Chem. 2004 Mar 19;279(12):11898-905
references.pmid: 14704146
references.citation: J Biol Chem. 2005 Feb 18;280(7):5892-901
references.pmid: 15590663
references.citation: Biochem Biophys Res Commun. 2007 Mar 2;354(1):234-9
references.pmid: 17222388
references.citation: Nat Med. 2000 Feb;6(2):143-50
references.pmid: 10655101